Your browser doesn't support javascript.
loading
Pituitary Function after High-Dose 177Lu-DOTATATE Therapy and Long-Term Follow-Up.
Sundlöv, Anna; Sjögreen-Gleisner, Katarina; Tennvall, Jan; Dahl, Ludvig; Svensson, Johanna; Åkesson, Anna; Bernhardt, Peter; Lindgren, Ola.
Afiliação
  • Sundlöv A; Department of Clinical Sciences, Oncology, and Pathology, Skåne University Hospital, Lund University, Lund, Sweden, anna.sundlov@med.lu.se.
  • Sjögreen-Gleisner K; Medical Radiation Physics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Tennvall J; Department of Clinical Sciences, Oncology, and Pathology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Dahl L; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Åkesson A; Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden.
  • Bernhardt P; Department of Radiation Physics, University of Gothenburg, Gothenburg, Sweden.
  • Lindgren O; Department of Clinical Sciences, Oncology, and Pathology, Skåne University Hospital, Lund University, Lund, Sweden.
Neuroendocrinology ; 111(4): 344-353, 2021.
Article em En | MEDLINE | ID: mdl-32259830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Hipófise / Fator de Crescimento Insulin-Like I / Octreotida / Tumores Neuroendócrinos / Compostos Radiofarmacêuticos / Gonadotropinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Hipófise / Fator de Crescimento Insulin-Like I / Octreotida / Tumores Neuroendócrinos / Compostos Radiofarmacêuticos / Gonadotropinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article